BioCryst Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(10.02%)
BioCryst Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(9.81%)
BioCryst Pharmaceuticals | 10-Q: Q3 2024 Earnings Report
BioCryst Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(9.81%)
BioCryst Pharmaceuticals | 8-K: BioCryst Reports Third Quarter 2024 Financial Results and Provides Business Update
BioCryst Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-STATE STREET CORPORATION :(4.3%)
BioCryst Pharmaceuticals | 8-K: Current report
BioCryst Pharmaceuticals | 8-K: Current report
BioCryst Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(10.2%)
BioCryst Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director MILANO VINCENT
BioCryst Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
BioCryst Pharmaceuticals | 10-Q: Q2 2024 Earnings Report
BioCryst Pharmaceuticals | 8-K: BioCryst Reports Second Quarter 2024 Financial Results and Provides Business Update
BioCryst Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director McKee Amy E
BioCryst Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
BioCryst Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director SANDERS MACHELLE
BioCryst Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
BioCryst Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director McKee Amy E
BioCryst Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director MILANO VINCENT
BioCryst Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director SANDERS MACHELLE
No Data
No Data